CSL is one of three tier one plasma therapy companies who benefit from an oligopoly in this highly consolidated market. All the players are vertically integrated as plasma sourcing is the most ...

Ask CSL Limited CEO and managing director Paul Perreault about his company’s uncommon origin story — it was founded by the Australian government in 1916 and not privatized until 1994 — and you receive ...

CSL Behring has been honored with this prestigious award recognizing innovation and excellence in pharmaceutical facility projects, as the FOYA program celebrates its 20 th anniversary "As FOYA marks ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business. Australia-based CSL, which runs a network of ...

Australia’s CSL has opened the first phase of a $170 million plasma products plant that will boost production for the U.S. and Europe as well as Asia-Pacific markets. CSL today said the new facility ...